Costo-efectividad consolidación de LMA pediátrica de riesgo intermedio en Colombia

Mario García-Molina (), Liliana Alejandra Chicaíza-Becerra (), Hoover Quitian-Reyes and Adriana Linares
Authors registered in the RePEc Author Service: Liliana Alejandra Chicaíza Becerra () and Mario García Molina

Coyuntura Económica, 2013

Abstract: Objetivo: evaluar la costo-efectividad del trasplante alogénico con progenitores hematopoyéticos, comparado con quimioterapia de consolidación, en pacientes menores de edad diagnosticados con Leucemia mieloide aguda (LMA) y estratificados en riego intermedio. Objective: To assess the cost-effectiveness of unrelated and related hematopoietic stem cell transplantations, versus chemotherapy consolidation in pediatric patients with intermediate-risk acute myeloid leukemia.

Keywords: Análisis Costo-Beneficio; Leucemia Mieloide Aguda; Quimioterapia, Transplante.Keywords: Cost-Benefit Analysis; Leukemia, Myeloid, Acute; Drug Therapy, Transplantation. (search for similar items in EconPapers)
JEL-codes: I12 I18 I38 (search for similar items in EconPapers)
Date: 2013
References: Add references at CitEc
Citations:

Downloads: (external link)
http://hdl.handle.net/11445/268

Related works:
This item may be available elsewhere in EconPapers: Search for items with the same title.

Export reference: BibTeX RIS (EndNote, ProCite, RefMan) HTML/Text

Persistent link: https://EconPapers.repec.org/RePEc:col:000438:012044

Access Statistics for this article

More articles in Coyuntura Económica from Fedesarrollo Contact information at EDIRC.
Bibliographic data for series maintained by Patricia Monroy ().